• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    12.22 Down 0.01(0.08%) Feb 5, 4:00PM EST
    |After Hours : 12.07 Down 0.15 (1.23%) Feb 5, 7:50PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.1
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:35.25
    Median Target:37.00
    High Target:56.00
    Low Target:15.00
    No. of Brokers:12

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 19, 2016RBC Capital MktsDowngradeOutperformSector Perform
    Jan 15, 2016Piper JaffrayDowngradeOverweightNeutral
    Oct 23, 2015JefferiesInitiated Hold
    Oct 2, 2015WedbushUpgradeNeutralOutperform
    Aug 24, 2015Piper JaffrayUpgradeNeutralOverweight
    Aug 7, 2015Sun Trust Rbsn HumphreyDowngradeBuyNeutral
    May 21, 2015BofA/MerrillDowngradeBuyNeutral
    May 20, 2015Sun Trust Rbsn HumphreyUpgradeNeutralBuy
    May 20, 2015Canaccord GenuityUpgradeHoldBuy
    May 6, 2015Robert W. BairdUpgradeNeutralOutperform

    More Upgrades & Downgrades for SRPT

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy6665
    Buy3344
    Hold5554
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.